Jung A - Search Results

1

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

Heinemann V, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Müller S, Link H, Niederle N, Rost A, Höffkes HG, Moehler M, Lindig RU, Modest DP, Rossius L, Kirchner T, Jung A, Stintzing S. Heinemann V, et al. Among authors: jung a. Lancet Oncol. 2014 Sep;15(10):1065-75. doi: 10.1016/S1470-2045(14)70330-4. Epub 2014 Jul 31. Lancet Oncol. 2014. PMID: 25088940 Clinical Trial.

2

[Regional cooperation in molecular biology topics].

Reymond MA, Köckerling F, Jung A, Kirchner T, Fuchs KH, Jauch H, Hohenberger W. Reymond MA, et al. Among authors: jung a. Langenbecks Arch Chir Suppl Kongressbd. 1997;114:370-1. Langenbecks Arch Chir Suppl Kongressbd. 1997. PMID: 9574157 German.

3

Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

Brabletz T, Jung A, Hermann K, Günther K, Hohenberger W, Kirchner T. Brabletz T, et al. Among authors: jung a. Pathol Res Pract. 1998;194(10):701-4. doi: 10.1016/s0344-0338(98)80129-5. Pathol Res Pract. 1998. PMID: 9820866

4

Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas.

Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Brabletz T, et al. Among authors: jung a. Am J Pathol. 2000 Mar;156(3):865-70. doi: 10.1016/s0002-9440(10)64955-3. Am J Pathol. 2000. PMID: 10702403 Free PMC article.

5

[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].

Brabletz T, Jung A, Dag S, Reu S, Kirchner T. Brabletz T, et al. Among authors: jung a. Verh Dtsch Ges Pathol. 2000;84:175-81. Verh Dtsch Ges Pathol. 2000. PMID: 11217438 German.

6

Beta-catenin and the morphogenesis of colorectal cancer.

Brabletz T, Jung A, Kirchner T. Brabletz T, et al. Among authors: jung a. Virchows Arch. 2002 Jul;441(1):1-11. doi: 10.1007/s00428-002-0642-9. Epub 2002 Apr 27. Virchows Arch. 2002. PMID: 12111194 Review.

7

Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.

Brueckl WM, Moesch C, Brabletz T, Koebnick C, Riedel C, Jung A, Merkel S, Schaber S, Boxberger F, Kirchner T, Hohenberger W, Hahn EG, Wein A. Brueckl WM, et al. Among authors: jung a. Anticancer Res. 2003 Mar-Apr;23(2C):1773-7. Anticancer Res. 2003. PMID: 12820457 Clinical Trial.

8

Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis.

Stintzing S, Heuschmann P, Barbera L, Ocker M, Jung A, Kirchner T, Neureiter D. Stintzing S, et al. Among authors: jung a. Ann Vasc Surg. 2005 May;19(3):310-9. doi: 10.1007/s10016-005-0003-7. Ann Vasc Surg. 2005. PMID: 15818457

9

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Brabletz T, et al. Among authors: jung a. Nat Rev Cancer. 2005 Sep;5(9):744-9. doi: 10.1038/nrc1694. Nat Rev Cancer. 2005. PMID: 16148886 Review.

10

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A, Kirchner T, Brabletz T. Spaderna S, et al. Among authors: jung a. Gastroenterology. 2006 Sep;131(3):830-40. doi: 10.1053/j.gastro.2006.06.016. Gastroenterology. 2006. PMID: 16952552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,783 results

Search Page